Historical Evidence of Treating Vitiligo in Medieval Persia

  • Parmis Badr Phytopharmaceutical Technology and Traditional Medicine Incubator, Shiraz University of Medical Sciences, Shiraz, Iran Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Farhad Handjani Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran
  • Abdolali Mohagheghzadeh Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran Department of Phytopharmaceuticals (Traditional Pharmacy), Shiraz University of Medical Sciences, Shiraz, Iran
Vitiligo, Baras, Bahaq, Traditional Persian Medicine, Qutb al-Din- Shirazi


Vitiligo is an acquired chronic skin disorder characterized by progressive loss of melanocytes from epidermis resulting in depigmented areas. Although various therapies for vitiligo, including topical and systemic corticosteroids, topical immunomodulators, phototherapy plus chemotherapy, tissue grafting techniques and depigmentation of normally pigmented skin are practiced, these modern methods are not always satisfactory. Vitiligo has been introduced in medieval manuscripts of Persia under two categories of Bahaq and Baras. Besides the diagnostic differences between these two disorders, a variety of formulations have been suggested by Iranian scholars for treatment or covering white patches. Extracting the ideas of our ancestors could both revive forgotten medicinal knowledge and also depict the contribution of one nation in progress of medicine and pharmacy.


Borderé AC, Lambert J, Geel NV, Current and emerging therapy for the management of vitiligo. Clin, Cosmet Investig Dermatol 2009;2:15-25.

Gianfaldoni S, Hercogová J, Lotti T, The Last Frontier Of Vitiligo Repigmentation, Aestheticians J 2014;4:34-37.

Aalam H. Monograph of Baras, Encyclopedia of the world of Islam (in Persian), 1998;3:111-113.

Millington G, Levell N J, Vitiligo: the historical curse of depigmentation. Int J Dermatol 2007;46:990-995.i

Holly Quran. Ale Imran: verse 49.

Akhawayini al-Bukhari. Hidayat al mutaallimin fi-al-ttib. Mashhad University Press. 1992; pp 593-595.

Avicena. Canon of Medicine. Vol 7. Soroush Press. 2008; pp 158-160.

Cheshti Hakim. Exir-e Azam. Vol 4. Lithography version. 1810; p 475.

Razi B. Kholasat-al-tajarob. Rahe Kamal Press. 2009; pp 182-184.

Arzani MA. Tibb-e- Akbari. Jalaleddin Press. Qom 2009; pp 1173-1176.

Raban Tabari A. Ferdos al-hikmat. Traditional Medicine & Materia Medica Research Center (TMRC). 2013; p 228.

Tonekaboni M. Tohfat-ol-momenin. Nashr Shahr Press. 2007; p 616.

Razi Z. Mansoori fi-al-ttib. Tehran University of Medical Sciences Press. 2009; pp 300-301.

Ghaeni Heravi SM. Gharabadin-e-Salehi. 1st ed. Choogan Press. 2013.

Qutb al-Din-Shirazi. Risale fi-al-Baras (Treatise on Vitiligo). Rasht

Hosseinkhani A, Montaseri H, Sodaifi M, Mohagheghzadeh A, Seradj H, Afshari-Jouybari A. randomized double blind clinical trial on a Sabgh formulation for patients with vitiligo. J Evid Based Complementary Altern Med 2015;20:254-258.

How to Cite
Badr P, Handjani F, Mohagheghzadeh A. Historical Evidence of Treating Vitiligo in Medieval Persia. Trad Integr Med. 2(4):166-171.
Research Article(s)